When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
On August 6th, Rigel Pharmaceuticals (RIGL), reported their Q2 earnings and updates on their flagship product, TAVALISSE. Rigel Pharmaceuticals recorded a beat on EPS of -$0.12 by $0.02 and revenue of $10.41M, which was a beat by $1.13M. It appears that Rigel has been executing with their TAVALISSE sales in chronic ITP, which has experienced a 26% growth in net product sales quarter-over-quarter. Following the earnings release the stock saw an abrupt rise in share price in after-hours; however, the subsequent trading day was a sea of red that quickly subdued the injection